Company intelligence / Profile preview

Southern.IML Pathology

Wollongong, New South Wales, Australiasouthernpath.com.au ↗

Ownership: Private
Employees: ~60
Development stage: Commercial

Overview

Southern.IML Pathology operates as a leading private pathology service in the Illawarra and South Coast regions of New South Wales. It offers a comprehensive range of diagnostic tests including clinical metagenomics for GI pathogens and Medicare-rebated genetic panels. The company supports clinicians with weekly reports and telehealth ordering tools.

Therapeutic areas: OtherWomen's HealthRare DiseasesInfectious Diseases
Modalities: Non-pharmacological therapy (diagnostic testing)Device (diagnostic devices for sample analysis)Molecular diagnostics (e.g., metagenomic and genetic testing)
Industry: Molecular Diagnostics

Partnerships

May participate in collaborative programs such as Sonic Genetics but no explicit major pharma/biotech partnerships listed.

Beyond the preview

Go deeper on Southern.IML Pathology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Southern.IML Pathology.

Explore the full profile